person · Reporting owner
Kochevar Deborah Turner
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | Director | May 13, 2024 | May 15, 2024 |
| Elanco Animal Health IncELAN · Entity 3457 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date May 13, 2024 · Filed May 15, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 7,894 |
Reported balance
After 2024-05-13 transaction · row 1
1 source rowRow 1 · 2024-05-13 · Grant · Acquired 559 · Balance 7,894 F1: The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $228.41 · Expires 2034-05-13 | Direct | 1,311 |
Reported balance
After 2024-05-13 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-05-13 · Grant · Acquired 1,311 · Balance 1,311 F2: The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The unvested restricted stock units vest upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
F2: The stock options become exercisable upon the earlier of 5/13/2025 or the business day prior to the Company's next annual meeting of shareholders.
Elanco Animal Health Inc
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 94,392 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 4,678 · Balance 94,392 F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of deferred stock units as a pro-rated annual equity award to each of the non-employee members of the Issuer's Board of Directors.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $123.39 | $24,677.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,990 Read SEC document |
| September 04, 2018 Filed Sep 5, 2018 19:28 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $123.23 | $36,969.00 |
DisclosureSEC source: 0001127602-18-026778 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,190 Read SEC document |
| May 14, 2018 Filed May 16, 2018 10:45 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,004 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-017570 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,490 F1 · kind: Consists of 2,004 unvested restricted stock units that vest upon the earlier of 5/14/2019, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $88.03 | $17,606.00 |
DisclosureSEC source: 0001127602-17-018189 · form4.xml · nonDerivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,486 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.02 | $8,802.00 |
DisclosureSEC source: 0001127602-17-018189 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,686 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 3,140 | $0.00 Strike: $70.29 | $0.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · derivative · entry 30 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,140 shares Expires 2020-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.01 | $8,801.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 29 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,786 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $88.01 | $8,800.50 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 28 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,886 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 600 | $88.00 | $52,800.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 27 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,986 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 210 | $88.00 | $18,478.95 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 26 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,586 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 301 | $87.99 | $26,484.99 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 25 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,796 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $87.99 | $17,597.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 24 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,097 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 337 | $87.98 | $29,649.26 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 23 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,297 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 590 | $87.97 | $51,902.30 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 22 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,634 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 122 | $87.97 | $10,731.73 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 21 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,224 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 278 | $87.96 | $24,452.88 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 20 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,346 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $87.96 | $17,591.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 19 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,624 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 290 | $87.95 | $25,505.50 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 18 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,824 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $87.94 | $35,176.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 17 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,114 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $87.93 | $17,586.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 16 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,514 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $87.93 | $26,377.50 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 15 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,714 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $87.92 | $17,584.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 14 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,014 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 10 | $87.92 | $879.15 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 13 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,214 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.91 | $8,790.50 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 12 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,224 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $87.89 | $35,156.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 11 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,324 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $87.89 | $26,365.50 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 10 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,724 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $87.88 | $35,152.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 9 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,024 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $87.87 | $26,361.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 8 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,424 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $87.85 | $17,569.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 7 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,724 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 232 | $87.84 | $20,378.88 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 6 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,924 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.83 | $8,782.50 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 5 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,156 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $87.82 | $8,782.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 4 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,256 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $87.81 | $43,905.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 3 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,356 Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 3,140 | $70.29 | $220,710.60 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 2 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,856 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2017 Filed May 16, 2017 15:01 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 2,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-018187 · form4.xml · nonDerivative · entry 1 Kochevar Deborah Turner · CIK 0001448579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,716 F1 · shares: Consists of 2,436 unvested restricted stock units that vest upon the earlier of 5/12/2018, or the business day prior to the Company's next annual meeting of shareholders. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.